India’s first phase-three trial for an indigenous tetravalent dengue vaccine, DengiALL, was initiated by Panacea Biotec. Conducted across 19 sites, the trial involves over 10,335 healthy adults. The vaccine aims to address all four dengue serotypes. The Union Health Minister J P Nadda highlighted its significance in combating dengue and enhancing India’s vaccine development capabilities.
Phase three clinical trial of India’s own dengue vaccine, DengiAll, initiated
Categories:
Related Post
FCC chair says it’s ‘really concerning’ that a Soros-backed radio station exposed undercover ICE agentsFCC chair says it’s ‘really concerning’ that a Soros-backed radio station exposed undercover ICE agents
Federal Communication Commission chairman Brendan Carr said it’s “really concerning” that a radio station backed by left-wing billionaire George Soros broadcasted live locations of undercover Immigration and Customs Enforcement (ICE) agents. Carr’s
Reporter’s Notebook: Chronicling the Assad regime from death of the father to defeat of the sonReporter’s Notebook: Chronicling the Assad regime from death of the father to defeat of the son
The dramatic and historic scenes coming out of Syria this week are a reminder of the horrors that country has been through in the last several decades. We were there
MPSC Postpones Civil Services Prelims Exam; Students Demand Inclusion of Agri PostsMPSC Postpones Civil Services Prelims Exam; Students Demand Inclusion of Agri Posts
The Maharashtra Public Service Commission (MPSC) has postponed the Maharashtra Gazetted Civil Services Combined Preliminary Examination 2024, initially scheduled for August 25, following protests by government-job aspirants. The protest, joined